| Literature DB >> 25331347 |
Eiji Yamada1, Masahiko Inamori1, Eri Uchida2, Emiko Tanida2, Motoyoshi Izumi2, Kimiya Takeshita3, Tetsuro Fujii4, Kazuto Komatsu5, Jun Hamanaka6, Shin Maeda1, Akira Kanesaki2, Nobuyuki Matsuhashi7, Atsushi Nakajima1.
Abstract
OBJECTIVES: No previous reports have shown an association between location of diverticular disease (DD) and the irritable bowel syndrome (IBS).Entities:
Mesh:
Year: 2014 PMID: 25331347 PMCID: PMC4261138 DOI: 10.1038/ajg.2014.323
Source DB: PubMed Journal: Am J Gastroenterol ISSN: 0002-9270 Impact factor: 10.864
Figure 1The flow diagram for this study. BD, bilateral diverticular disease; IBS, irritable bowel syndrome; LD, left-sided diverticular disease; n, number.
Patients' characteristics
| Age (s.d.; years) | 64.2±12.9 |
| Gender (M:F) | 1.62:1 |
| Mean BMI (s.d.) | 22.9±3.5 |
| Smoker % | 17.4 |
| Alcohol % | 41.8 |
| Laxative use % | 14.8 |
| NSAIDs % | 1.5 |
| Aspirin % | 7.0 |
| Previous cholecystectomy % | 5.0 |
| History of acute colonic diverticulitis | 5.2% |
| Married % | 79.6 |
| MCS (<50) % | 51.4 |
| RD | 21.6% |
| LD | 6.6% |
| BD | 12.0% |
| IBS | 7.5% |
BD, bilateral diverticular disease; BMI, body mass index; IBS, irritable bowel syndrome; LD, left-sided diverticular disease; MCS, mental component summary; n, number; NSAID, non-steroidal anti-inflammatory drug; RD, right-sided diverticular disease.
Comparison of the IBS group and non-IBS group
| Age (s.d.; years) | 65.8±13.7 | 64.1±12.8 | 0.2649S |
| ≤65 years | 64.5% | 56.6% | 0.1818C |
| Gender (M:F) | 1.17:1 | 1.67:1 | 0.1406C |
| Mean BMI (s.d.) | 22.4±3.4 | 23.0±3.5 | 0.1822S |
| Smoker % | 14.5 | 17.8 | 0.4645C |
| Alcohol % | 42.1 | 41.8 | 0.9587C |
| Laxative use % | 27.6 | 13.7 | 0.0010C* |
| NSAIDs % | 3.9 | 1.3 | 0.0653C |
| Aspirin % | 7.7 | 7.0 | 0.7610C |
| Previous cholecystectomy % | 3.9 | 5.0 | 0.6737C |
| History of acute colonic diverticulitis | 2.6% | 5.4% | 0.3011C |
| Married % | 77.6 | 80.9 | 0.4848C |
| MCS (<50) % | 79.1 | 49.0 | 0.0001C* |
| RD | 18.4% | 21.9% | 0.4830 C |
| LD | 18.4% | 5.68% | 0.0002C* |
| BD | 19.7% | 11.4% | 0.0307C* |
BD, bilateral diverticular disease; BMI, body mass index; IBS, irritable bowel syndrome; LD, left-sided diverticular disease; MCS, mental component summary; n, number; NSAID, non-steroidal anti-inflammatory drug; RD, right-sided diverticular disease. C χ2-Test, S Student's t test. *(P < 0.05).
Results of the multiple logistic regression analysis for independent risk for IBS
| Odds ratio | 95% CI | ||
|---|---|---|---|
| Male | 0.7 | 0.4–1.1 | 0.1466 |
| ≤65 years | 1.2 | 0.7–2.0 | 0.5863 |
| NSAIDs | 2.0 | 0.5–8.1 | 0.3069 |
| MCS (<50) | 3.7 | 2.0–6.9 | 0.0001* |
| RD | 0.9 | 0.5–1.9 | 0.8873 |
| LD | 3.1 | 1.4–7.1 | 0.0060* |
| BD | 2.6 | 1.3–5.2 | 0.0070* |
CI, confidence interval; NSAID, non-steroidal anti-inflammatory drug; MCS, mental component summary; RD, right-sided diverticular disease; LD, left-sided diverticular disease; BD, bilateral diverticular disease. *(P < 0.05).
Association between IBS subtype and location of DD
| D-IBS (%) | 1.4 | 9.0 | 2.5 | |||
| 1.3 (0.3–5.1) | 0.7041 | 8.8 (2.5–30.8) | 0.0006* | 2.8 (0.7–11.3) | 0.1524 | |
| C-IBS (%) | 0.9 | 1.5 | 1.7 | |||
| 1.5 (0.3–8.1) | 0.653 | 2.3 (0.3–21.1) | 0.4621 | 2.7 (0.5–14.9) | 0.2574 | |
| M-IBS (%) | 0.9 | 1.5 | 1.7 | |||
| 5.5 (0.5–60.8) | 0.1674 | 8.2 (0.5–138.7) | 0.1466 | 9.2 (0.8–104.3) | 0.0726 | |
| U-IBS (%) | 3.2 | 9.0 | 6.6 | |||
| 0.9 (0.4–2.2) | 0.8806 | 3.1 (1.2–8.2) | 0.0235* | 2.1 (0.9–4.8) | 0.1021 |
BD, bilateral diverticular disease; CI, confidence interval; C-IBS, constipation-predominant IBS; DD, diverticular disease; IBS, irritable bowel syndrome; LD, left-sided diverticular disease; M-IBS, mixed IBS; n, number; OR, odds ratio; RD, right-sided diverticular disease; U-IBS, un-subtype IBS.
Figure 2Overlaps of RD and LD with IBS. IBS, irritable bowel syndrome; n, number; LD, left-sided diverticular disease; RD, right-sided diverticular disease.